Back
Blackbaud Vs. Halozyme Therapeutics Industry Stock Comparison
Buy
56
BLKB
Blackbaud
Last Price:
$63.50
Seasonality Move:
3.06%
Buy
65
HALO
Halozyme Therapeutics
Last Price:
$57.16
Seasonality Move:
-2.69%
Buy
65
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics a Buy, Sell or Hold?
-
The current Halozyme Therapeutics [HALO] share price is $57.15. The Score for HALO is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
HALO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $57.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing slight selling pressure.
BLKB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.72 | Buy |
Relative Strength Index (14 RSI): | 48.21 | Sell |
Chaikin Money Flow: | -142420 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (61.85 - 65.39) | Buy |
Bollinger Bands (100): | (60.66 - 66.82) | Sell |
HALO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 12.67 | Buy |
Relative Strength Index (14 RSI): | 62.41 | Buy |
Chaikin Money Flow: | -398870 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (52.53 - 55.41) | Buy |
Bollinger Bands (100): | (53.6 - 62.34) | Sell |
BLKB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 65.41 | Sell |
20-day SMA: | 63.76 | Sell |
50-day SMA: | 63.15 | Buy |
200-day SMA: | 72.19 | Sell |
8-day EMA: | 65 | Sell |
20-day EMA: | 64.3 | Sell |
50-day EMA: | 63.84 | Sell |
200-day EMA: | 69.15 | Sell |
HALO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.27 | Buy |
20-day SMA: | 53.97 | Buy |
50-day SMA: | 55.45 | Buy |
200-day SMA: | 55.44 | Buy |
8-day EMA: | 36.1 | Buy |
20-day EMA: | 18.76 | Buy |
50-day EMA: | 8.4 | Buy |
200-day EMA: | 2.23 | Buy |
Blackbaud Earnings Growth & BLKB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.11 per share, an increase this year of $0.16 per share, and an increase next year of $0.34 per share.
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, an increase next quarter of $0.09 per share, an increase this year of $1.19 per share, and an increase next year of $1.27 per share.
Blackbaud Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Halozyme Therapeutics Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |